Increased oxidative stress in sarcoidosis is known to be associated with clinical outcomes such as alveolar epithelial damage and fibrosis, PON1 deficiency may facilitate the pulmonary effects of sarcoidosis. This evidence concerns the gene PON1 and sarcoidosis.